CCAP

Crescent Capital BDC, Inc. [CCAP] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CCAP Stock Summary

Top CCAP Correlated Resources

CCAP


Top 10 Correlated ETFs

CCAP


Top 10 Correlated Stocks

CCAP


In the News

10:31 28 Mar 2024 CCAP

Is It Worth Investing in Crescent Capital BDC (CCAP) Based on Wall Street's Bullish Views?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

07:21 28 Mar 2024 CCAP

Crescent Capital BDC (CCAP) Increases Yet Falls Behind Market: What Investors Need to Know

Crescent Capital BDC (CCAP) closed at $17.50 in the latest trading session, marking a +0.81% move from the prior day.

10:21 28 Mar 2024 CCAP

3 SBIC & Commercial Finance Stocks to Buy Amid Grim Industry Prospects

Weak asset quality, high rates and macroeconomic woes are likely to hurt Zacks SBIC & Commercial Finance industry players like Bain Capital (BCSF), Barings BDC (BBDC) and Crescent Capital (CCAP). Yet, decent financing demand across sectors is likely to aid.

07:21 28 Mar 2024 CCAP

Here's Why Crescent Capital BDC (CCAP) Fell More Than Broader Market

Crescent Capital BDC (CCAP) closed at $16.99 in the latest trading session, marking a -1.51% move from the prior day.

04:58 28 Mar 2024 CCAP

Crescent Capital Is Well Set To Sustain Gains Over The Long Term

Crescent Capital is a top BDC with the potential for solid long-term returns and downside protection through diversified debt investments. The company's outlook for 2024 is promising due to growth trends in the leveraged buyout market and improving end markets. CCAP is well-positioned to benefit from increased LBO activity with strong relationships with private equity sponsors and solid liquidity.

10:31 28 Mar 2024 CCAP

Is Crescent Capital BDC (CCAP) a Buy as Wall Street Analysts Look Optimistic?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

07:01 28 Mar 2024 CCAP

Crescent Capital BDC (CCAP) Increases Despite Market Slip: Here's What You Need to Know

In the closing of the recent trading day, Crescent Capital BDC (CCAP) stood at $16.27, denoting a +0.93% change from the preceding trading day.

07:01 28 Mar 2024 CCAP

Crescent Capital BDC (CCAP) Stock Dips While Market Gains: Key Facts

The latest trading day saw Crescent Capital BDC (CCAP) settling at $16.12, representing a -0.31% change from its previous close.

04:15 28 Mar 2024 CCAP

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2023 Financial Results

LOS ANGELES, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2023 on Wednesday, February 21, 2024 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Thursday, February 22, 2024 at 12:00 p.m. Eastern Time to discuss its fourth quarter and fiscal year ended December 31, 2023 financial results.

07:21 28 Mar 2024 CCAP

Crescent Capital BDC (CCAP) Stock Sinks As Market Gains: Here's Why

In the closing of the recent trading day, Crescent Capital BDC (CCAP) stood at $16.54, denoting a -0.72% change from the preceding trading day.

CCAP Financial details

Company Rating
Strong Buy
Market Cap
652.28M
Income
83.84M
Revenue
115.67M
Book val./share
20.04
Cash/share
0.21
Dividend
1.73
Dividend %
10.09%
Employees
-
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
11.44
Forward P/E
8.54
PEG
22.46
P/S
7.27
P/B
0.87
P/C
82.6
P/FCF
6.39
Quick Ratio
2.14
Current Ratio
1.63
Debt / Equity
1.14
LT Debt / Equity
1.14
-
-
EPS (TTM)
2.27
EPS next Y
2.03
EPS next Q
0.58
EPS this Y
7.87%
EPS next Y
-10.68%
EPS next 5Y
-10.68%
EPS last 5Y
19.16%
Revenue last 5Y
29.61%
Revenue Q/Q
-31.4%
EPS Q/Q
40.68%
-
-
-
-
SMA20
-
SMA50
-
SMA100
6.25%
Inst Own
46.42%
Inst Trans
0.83%
ROA
3%
ROE
8%
ROC
0.05%
Gross Margin
100%
Oper. Margin
88%
Profit Margin
64%
Payout
106%
Shs Outstand
37.06M
Shs Float
30.34M
-
-
-
-
Target Price
18.5
52W Range
13.11-18.0
52W High
-3.64%
52W Low
+33.42%
RSI
50
Rel Volume
0.49
Avg Volume
98.23K
Volume
48.26K
Perf Week
-0.89%
Perf Month
5.7%
Perf Quarter
5.44%
Perf Half Y
-0.49%
-
-
-
-
Beta
0.887
-
-
Volatility
0.26%, 0.36%
Prev Close
1.85%
Price
17.345
Change
0.49%

CCAP Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.841.682.860.732.57
Net income per share
0.971.982.940.562.33
Operating cash flow per share
-6.76-2.23-5.541.012.57
Free cash flow per share
-6.76-2.23-5.541.012.57
Cash per share
0.150.070.350.230.68
Book value per share
13.5520.2322.9122.1320.67
Tangible book value per share
13.5520.2322.9122.1320.67
Share holders equity per share
13.5520.2322.9122.1320.67
Interest debt per share
11.1217.6122.8524.7925.04
Market cap
492.64M403.32M501.21M353.77M624.43M
Enterprise value
810.08M873.36M1.12B1B1.46B
P/E ratio
16.837.385.9922.767.45
Price to sales ratio
19.498.676.1617.496.75
POCF ratio
-2.43-6.53-3.1812.666.77
PFCF ratio
-2.43-6.53-3.1812.666.77
P/B Ratio
1.210.720.770.580.84
PTB ratio
1.210.720.770.580.84
EV to sales
32.0518.7713.849.5415.81
Enterprise value over EBITDA
27.3315.7612.8622.0517.38
EV to operating cash flow
-3.99-14.13-7.1235.8415.83
EV to free cash flow
-3.99-14.13-7.1235.8415.83
Earnings yield
0.060.140.170.040.13
Free cash flow yield
-0.41-0.15-0.310.080.15
Debt to equity
0.790.840.971.071.14
Debt to assets
0.430.450.480.50.52
Net debt to EBITDA
10.718.487.1114.269.95
Current ratio
0.630.371.740.761.47
Interest coverage
2.463.584.421.521.53
Income quality
-6.93-1.13-1.891.81.1
Dividend Yield
0.050.110.10.160.1
Payout ratio
0.840.780.573.560.77
Sales general and administrative to revenue
0.140.10.060.220.05
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
293.76K0.66164.3700.44
Graham number
17.2429.9838.916.7232.94
ROIC
0.040.050.070.040.05
Return on tangible assets
0.040.050.060.010.05
Graham Net
-11.1-17.34-22.45-23.95-23.65
Working capital
-4.53M-9.71M13.53M-5.3M12.38M
Tangible asset value
406.92M560M652.29M612.54M742.59M
Net current asset value
-332.69M-488.39M-633.82M-673.99M-846.32M
Invested capital
0.790.840.971.071.14
Average receivables
2.18M3.43M12.75M15.79M12.1M
Average payables
9.8M13.79M16.82M19.91M23.87M
Average inventory
0.59.36M9.36M13.51M13.51M
Days sales outstanding
43.2130.3297.09179.5856.26
Days payables outstanding
940.52834.66340.73386.08260.25
Days of inventory on hand
01.01K0481.810
Receivables turnover
8.4512.043.762.036.49
Payables turnover
0.390.441.070.951.4
Inventory turnover
4.7M0.3619.47M0.760
ROE
0.070.10.130.030.11
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.170.310.661.30.89
Net income per share
0.090.240.610.610.83
Operating cash flow per share
1.510.490.550.580.93
Free cash flow per share
1.510.490.550.580.93
Cash per share
0.230.660.580.610.21
Book value per share
22.1322.1319.5819.720.04
Tangible book value per share
22.1322.1319.5819.720.04
Share holders equity per share
22.1322.1319.5819.720.04
Interest debt per share
24.0127.3323.5723.523.19
Market cap
353.77M442.18M561.11M633.75M644.13M
Enterprise value
1B1.3B1.41B1.48B1.48B
P/E ratio
33.9914.216.2175.22
Price to sales ratio
73.9844.3822.8913.1619.5
POCF ratio
8.4527.6227.5929.6818.62
PFCF ratio
8.4527.6227.5929.6818.62
P/B Ratio
0.580.620.770.870.87
PTB ratio
0.580.620.770.870.87
EV to sales
209.5130.1257.6330.8344.84
Enterprise value over EBITDA
76.5367.8963.2867.2547.82
EV to operating cash flow
23.948169.4769.5242.8
EV to free cash flow
23.948169.4769.5242.8
Earnings yield
0.010.020.040.040.05
Free cash flow yield
0.120.040.040.030.05
Debt to equity
1.071.221.181.171.14
Debt to assets
0.50.540.530.530.52
Net debt to EBITDA
49.544.7438.1538.5427.02
Current ratio
0.761.571.351.630.84
Interest coverage
1.281.691.561.532.09
Income quality
16.082.060.90.941.12
Dividend Yield
0.040.030.030.030.03
Payout ratio
4.871.630.670.80.6
Sales general and administrative to revenue
0.230.120.050.020.04
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00-0.030.030
Graham number
6.8410.9216.3816.4519.37
ROIC
0.010.010.010.010.02
Return on tangible assets
000.010.010.02
Graham Net
-23.95-26.96-23.43-22.99-22.85
Working capital
-5.3M12.73M8.64M14.36M-4.06M
Tangible asset value
612.54M718.42M725.81M730.27M742.59M
Net current asset value
-673.99M-877.82M-865.59M-857.04M-862.75M
Invested capital
1.071.221.181.171.14
Average receivables
9.17M15.55M16.45M18.88M20.12M
Average payables
19.73M21.91M23.38M23.71M24.46M
Average inventory
13.51M13.51M0.5019.36M
Days sales outstanding
187.26190.9743.248.5938.83
Days payables outstanding
319.73249.02239.55215.18239.72
Days of inventory on hand
399000355.71
Receivables turnover
0.480.472.081.852.32
Payables turnover
0.280.360.380.420.38
Inventory turnover
0.238.01M000.25
ROE
00.010.030.030.04
Capex per share
00000

CCAP Frequently Asked Questions

What is Crescent Capital BDC, Inc. stock symbol ?

Crescent Capital BDC, Inc. is a US stock , located in Los angeles of Ca and trading under the symbol CCAP

Is Crescent Capital BDC, Inc. buy or a sell ?

1 stock analysts have 1 predictions with a medium analyst target price of $18.5. The lowest prediction is $18.5 and the highest is $18.5

What is CCAP stock prediction ?

What is Crescent Capital BDC, Inc. stock quote today ?

Crescent Capital BDC, Inc. stock price is $17.345 today.

Is Crescent Capital BDC, Inc. stock public?

Yes, Crescent Capital BDC, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap